03:35 PM EDT, 06/26/2025 (MT Newswires) -- Health care stocks edged up late Thursday afternoon with the NYSE Health Care Index rising 0.1% and the Health Care Select Sector SPDR Fund (XLV) little changed, paring earlier gains.

The iShares Biotechnology ETF (IBB) added 0.1%.

In corporate news, Vor Biopharma ( VOR ) shares surged 82%, a day after the company signed a license deal with RemeGen for global rights, excluding Greater China, to develop and commercialize telitacicept for autoimmune diseases.